|
1
|
Hamm CW, Bassand JP, Agewall S, Bax J,
Boersma E, Bueno H, Caso P, Dudek D, Gielen S, Huber K, et al: ESC
Committee for Practice Guidelines: ESC Guidelines for the
management of acute coronary syndromes in patients presenting
without persistent ST-segment elevation: The Task Force for the
management of acute coronary syndromes (ACS) in patients presenting
without persistent ST-segment elevation of the European Society of
Cardiology (ESC). Eur Heart J. 32:2999–3054. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Task Force on the management of ST-segment
elevation acute myocardial infarction of the European Society of
Cardiology (ESC), ; Steg PG, James SK, Atar D, Badano LP,
Blömstrom-Lundqvist C, Borger MA, Di Mario C, Dickstein K, Ducrocq
G, Fernandez-Aviles F, et al: ESC Guidelines for the management of
acute myocardial infarction in patients presenting with ST-segment
elevation. Eur Heart J. 33:2569–2619. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Torbicki A, Perrier A, Konstantinides S,
Agnelli G, Galiè N, Pruszczyk P, Bengel F, Brady AJ, Ferreira D,
Janssens U, et al: ESC Committee for Practice Guidelines (CPG):
Guidelines on the diagnosis and management of acute pulmonary
embolism: The task force for the diagnosis and management of acute
pulmonary embolism of the European society of cardiology (ESC). Eur
Heart J. 29:2276–2315. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nienaber CA and Powell JT: Management of
acute aortic syndromes. Eur Heart J. 33:26–35b. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Amerian Cancer Society, . Cancer Facts and
Figures 2009. American Cancer Society; Atlanta, USA: 2009
|
|
6
|
Kukla P, Długopolski R, Krupa E, Furtak R,
Mirek-Bryniarska E, Szełemej R, Jastrzębski M, Nowak J, Kulak L,
Hybel J, et al: How often pulmonary embolism mimics acute coronary
syndrome? Kardiol Pol. 69:235–240. 2011.PubMed/NCBI
|
|
7
|
Dalen JE: Pulmonary embolism: What have we
learned since Virchow? Natural history, pathophysiology, and
diagnosis. Chest. 122:1440–1456. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Decastro GJ and McKiernan JM:
Epidemiology, clinical staging, and presentation of renal cell
carcinoma. Urol Clin North Am. 35:581–592. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kearon C: Natural history of venous
thromboembolism. Circulation. 107:(23 Suppl 1). I22–I30. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gibbons RP, Monte JE, Correa RJ Jr and
Mason JT: Manifestations of renal cell carcinoma. Urology.
8:201–206. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Monreal M, Fernandez-Llamazares J,
Perandreu J, Urrutia A, Sahuquillo JC and Contel E: Occult cancer
in patients with venous thromboembolism: Which patients, which
cancers. Thromb Haemost. 78:1316–1318. 1997.PubMed/NCBI
|
|
12
|
Hettiarachchi RJ, Lok J, Prins MH, Büller
HR and Prandoni P: Undiagnosed malignancy in patients with deep
vein thrombosis: Incidence, risk indicators, and diagnosis. Cancer.
83:180–185. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schulman S and Lindmarker P: Incidence of
cancer after prophylaxis with warfarin against recurrent venous
thromboembolism. Duration of Anticoagulation Trial. N Engl J Med.
342:1953–1958. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Connolly GC and Francis CW:
Cancer-associated thrombosis. Hematology Am Soc Hematol Educ
Program. 2013:684–691. 2013.PubMed/NCBI
|
